Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
This study has been completed.
Study NCT00002293 Information provided by Bristol-Myers Squibb
First Received: November 2, 1999 Last Updated: October 1, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Candidiasis, Oral
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Candidiasis
Communicable Diseases
Infection
Syndrome
More general conditions related to this trial
Disease
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mouth Diseases
Mycoses
Pathologic Processes
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Stomatognathic Diseases
Virus Diseases
Interventions listed in this trial
Nystatin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antifungal Agents
Ionophores
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bristol-Myers Squibb
Back to top of Main Content
